The effect of Helicobacter Pylori eradication on the level of platelet in chronic Idiopathic Thrombocytopenic Purpura patients

The Comparison of Helicobacter Pylori eradication on the level of platelet in chronic Idiopathic Thrombocytopenic Purpura patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201603077677N4

Enrollment

Registered

2016-08-28

Start date

2015-10-07

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic idiopathic thrombocytopenic purpura. Idiopathic Thrombocytopenic purpura

Interventions

Intervention 1: tab metronidazole 500mg each 12h tab clarithromycine 500 or 250 mg each 12h tab omeperazole 20 mg each 12h duration of treatment is 3 weeks(21 days). Intervention 2: in control group a

Treatment - Drugs

Placebo

tab metronidazole 500mg each 12h tab clarithromycine 500 or 250 mg each 12h tab omeperazole 20 mg each 12h duration of treatment is 3 weeks(21 days)

in control group according to the coordination with pharmacy company and gastroenterologist the placebo therapy will give

Eligibility

Sex/Gender

All

Age

11 Months to 17 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: platelet level 6 months; rule out other causes decreasing platelet level; helicobacter pylori infection that diagnosed by stool anti-gene test.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Platelet level. Timepoint: Before intervention, 1 month, 2 months and 3 months after intervention. Method of measurement: Blood platelet level (CBC).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammad Reza Golpayegani

Kermanshah University of Medical Sciences

golpayegani@kums.ac.ir+98 83 3721 8207

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026